Literature DB >> 12570727

Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formation.

Piero Portincasa1, Antonio Moschetta, Giuseppe Calamita, Antonio Margari, Giuseppe Palasciano.   

Abstract

The primum movens in cholesterol gallstone formation is hypersecretion of hepatic cholesterol, chronic surpersaturation of bile with cholesterol and rapid precipitation of cholesterol crystals in the gallbladder from cholesterol-enriched vesicles. Associated events include biochemical defects (increased biliary mucin, and increased proportions of hydrophobic bile salts in the intestine and gallbladder), motility defects (gallbladder smooth muscle hypocontractility in vitro and gallbladder stasis in vivo, sluggish intestinal transit), and an abnormal genetic background. The study of physical-chemical factors and pathways leading to cholesterol crystallization in bile has clinical relevance and the task can be carried out in different ways. The lithogenicity of bile is investigated in artificial model biles made by three biliary lipids - cholesterol, bile salts and phospholipids - variably combined in systems plotting within the equilibrium ternary phase diagram; also, crystallization propensity of ex vivo incubated human bile is studied by biochemical analysis of precipitated crystals, polarizing quantitative light microscopy and turbidimetric methods. The present review will focus on the recent advances in the field of pathobiology of cholesterol gallstones, by underscoring the role of early events like water transport, lipid transport, crystallization phenomena - including a genetic background - in gallstone pathogenesis. Agents delaying or preventing precipitation of cholesterol crystals and gallstone formation in bile will also be discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12570727

Source DB:  PubMed          Journal:  Curr Drug Targets Immune Endocr Metabol Disord        ISSN: 1568-0088


  4 in total

1.  Expression profiling suggests a regulatory role of gallbladder in lipid homeostasis.

Authors:  Zuo-Biao Yuan; Tian-Quan Han; Zhao-Yan Jiang; Jian Fei; Yi Zhang; Jian Qin; Zhi-Jie Tian; Jun Shang; Zhi-Hong Jiang; Xing-Xing Cai; Yu Jiang; Sheng-Dao Zhang
Journal:  World J Gastroenterol       Date:  2005-04-14       Impact factor: 5.742

2.  Disruption of gallbladder smooth muscle function is an early feature in the development of cholesterol gallstone disease.

Authors:  B Lavoie; B Nausch; E A Zane; M R Leonard; O B Balemba; A C Bartoo; R Wilcox; M T Nelson; M C Carey; G M Mawe
Journal:  Neurogastroenterol Motil       Date:  2012-05-24       Impact factor: 3.598

3.  A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans.

Authors:  Sobha Puppala; Gerald D Dodd; Sharon Fowler; Rector Arya; Jennifer Schneider; Vidya S Farook; Richard Granato; Thomas D Dyer; Laura Almasy; Christopher P Jenkinson; Andrew K Diehl; Michael P Stern; John Blangero; Ravindranath Duggirala
Journal:  Am J Hum Genet       Date:  2006-01-06       Impact factor: 11.025

4.  Determination of chemical composition of gall bladder stones: basis for treatment strategies in patients from Yaounde, Cameroon.

Authors:  Fru F Angwafo; Samuel Takongmo; Donald Griffith
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.